CohBar Company Description

CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases.

It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.

CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.

CohBar, Inc.

Country	United States
Founded	2007
Industry	Biotechnology
Sector	Healthcare
Employees	10

Contact Details

Address: 1455 Adams Drive Menlo Park, Delaware 94025 United States
Phone	650 446 7888
Website	cohbar.com

Stock Details

Ticker Symbol	CWBR
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US19249J1097
SIC Code	2836

Key Executives

Name	Position
Dr. Pinchas Cohen Dean, M.D., Ph.D.	Founder and Member of Scientific Advisory Board
Dr. Nir Yacov Barzilai M.D.	Founder and Member of Scientific Advisory Board
Dr. John M. Amatruda M.D., Ph.D.	Co-Founder
Jordyn Tarazi	Director of Investor Relations